Close Menu

NEW YORK – Celsius Therapeutics said Wednesday that it has signed collaboration agreements with the University of Oxford in the UK, the Cleveland Clinic in the US, and LMU University Hospital Munich in Germany to apply single-cell analytics technology to research into inflammatory bowel disease.

The Cambridge, Massachusetts-based vendor will lend its proprietary single-cell genomics platform and machine-learning technology to analyze longitudinal biopsies at three different stages.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.